Despite all the tumult in the markets, the underlying data—which comes in with a lag—suggests the economy is still faring ...

The Federal Reserve has likely come across your radar at some point. Often referred to as simply "the Fed," this central ...

Wall Street bounced between small gains and losses in meek trading as markets await the latest data from the retail sector ...

US Treasury yields remained within the week's highs as market mood shifted positively on news that the US and China had ...

The Australian Unemployment Rate has held around 4% since April 2024, easing towards 3.9% in November and peaking at 4.1% in ...

Hyperbole aside, last month’s inflation rate was lower than economists expected. But some analysts believe the relatively strong report could be the final calm before the storm, as American firms ...

The scale of the move was a reminder that the apparent stability of the Taiwan dollar has long rested on a fragile equilibrium. After all, Taiwan’s dollar is structurally weak, and there all sorts of ...

Most U.S. stocks rose Tuesday following an encouraging report that showed inflation had unexpectedly slowed across the ...

“There’s absolutely no whiff of a wage price spiral in our economy and that’s because we’ve been getting these decent wages ...

Pharma firm GSK has agreed to buy liver disease medicine efimosfermin from US firm Boston Pharmaceuticals, for up to $2 billion in cash. The sum will consist of a $1.2 billion upfront payment and ...